Latest Earnings Results: Q3 '26
Estimated EPS
-$0.13
Reported EPS
-$0.12
Surprise
+5.62%
Estimated Rev
$3.49M
Reported Rev
$3.99M
Surprise
+14.34%
• Reported GAAP EPS of -$0.12 up 14.29% YoY • Reported revenue of $3.99M up 78.12% YoY • OmniAb raised 2026 revenue guidance to $35M to $39M and expects costs and operating expenses of $83M to $87M, with year-end cash and cash equivalents of $53M to $57M.
Bullish Takeaway
OmniAb expanded xPloration access into a market opportunity above $500M, entered a Lilly collaboration eligible for up to $370M in milestones plus royalties, and reported positive partner-program developments.
Bearish Takeaway
OmniAb reported a Q3 2026 net loss and higher cash costs and operating expenses than Q3 2025, while success depends on partner development and commercialization and reliance on a limited number of third-party manufacturers.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.13 | -- | -- | N/A |
Q3 '26 | -$0.13 | -$0.12 | 5.62% | BEAT |
Q2 '26 | -$0.12 | -$0.05 | 58.33% | BEAT |
Q1 '26 | -$0.10 | -$0.06 | 42.47% | BEAT |
Q4 '25 | -$0.09 | -$0.11 | -25.04% | MISSED |